Alcon Stock

Alcon Revenue

The The revenue of Alcon (ALC.SW) as of Jul 22, 2026 is 10.40 B USD. In the previous year, The revenue was 9.91 B USD — a change of 4.94% (higher).

Revenue

10.40 BUSD

YoY

4.94%

Last updated:

In 2026, Alcon's sales reached 10.40 B USD, a 4.94% difference from the 9.91 B USD sales recorded in the previous year.

Revenue has compounded at 5.2% per year over the past 9 years to 10.40 B USD.

The Alcon Revenue history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

REVENUE (B USD)
GROSS MARGIN (%)
Date
REVENUE (B USD)
GROSS MARGIN (%)
Jan 1, 2024
9.91 base
55.65 base
Jan 1, 2025
10.40 base
56.30 base
Jan 1, 2026 (e)
11.23 base
52.13 base
Jan 1, 2027 (e)
11.96 base
48.98 base
Jan 1, 2028 (e)
12.86 base
45.53 base
Jan 1, 2029 (e)
13.42 base
43.64 base
Jan 1, 2030 (e)
14.25 base
41.09 base
Jan 1, 2031 (e)
14.30 base
40.95 base
YEARREVENUE (B USD)GROSS MARGIN (%)
2031 est 14.3040.95
2030 est 14.2541.09
2029 est 13.4243.64
2028 est 12.8645.53
2027 est 11.9648.98
2026 est 11.2352.13
2025 10.4056.30
2024 9.9155.65
2023 9.4655.57
2022 8.7255.17
2021 8.2956.64
2020 6.8345.24
2019 7.5148.69
2018 7.1549.90
2017 6.7947.17
2016 6.6047.45
Access this data via the Eulerpool API

Alcon Revenue

Alcon Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2024
9.91 B USD
1.35 B USD
1.02 B USD
Jan 1, 2025
10.40 B USD
1.42 B USD
980.00 M USD
Jan 1, 2026 (e)
11.23 B USD
2.21 B USD
1.69 B USD
Jan 1, 2027 (e)
11.96 B USD
2.49 B USD
1.95 B USD
Jan 1, 2028 (e)
12.86 B USD
2.80 B USD
2.25 B USD
Jan 1, 2029 (e)
13.42 B USD
3.28 B USD
2.56 B USD
Jan 1, 2030 (e)
14.25 B USD
3.58 B USD
2.85 B USD
Jan 1, 2031 (e)
14.30 B USD
0.00 USD
0.00 USD

Alcon Margins

Alcon stock margins

The Alcon margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Alcon. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Alcon.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2024
55.65 %
13.66 %
10.27 %
Jan 1, 2025
56.30 %
13.60 %
9.42 %
Jan 1, 2026 (e)
56.30 %
19.66 %
15.04 %
Jan 1, 2027 (e)
56.30 %
20.86 %
16.33 %
Jan 1, 2028 (e)
56.30 %
21.78 %
17.48 %
Jan 1, 2029 (e)
56.30 %
24.42 %
19.09 %
Jan 1, 2030 (e)
56.30 %
25.13 %
20.00 %
Jan 1, 2031 (e)
56.30 %
0.00 %
0.00 %

Alcon Stock analysis

What does Alcon do? Alcon AG is a leading company in ophthalmology with more than 70 years of experience in this industry. The company was founded in 1945 by Robert Alexander and William Conner and has its headquarters in Geneva, Switzerland. Alcon AG has been part of the Novartis Group since 2019 and is a leader in the production of ophthalmic products. The business model of Alcon AG is based on the manufacturing and sale of ophthalmic products. The company offers medical products such as contact lenses, surgical instruments, eye drops, and intraocular lenses. Alcon AG specializes in the development of products that can be used for various eye diseases. The company provides a wide range of products that can be used by ophthalmologists and opticians. The various divisions of Alcon AG include eye care products, surgical products, and diagnostic products. Eye care products, such as contact lenses, offer consumers a safe and easy way to correct their vision. Surgical products include a wide range of instruments used in eye surgeries. Diagnostic products help identify eye diseases and support treatment. Alcon AG specializes in the development of products for the treatment of eye diseases. These include conditions such as cataracts, glaucoma, and age-related macular degeneration. The company offers various products that can be used for these conditions, such as eye drops to reduce elevated eye pressure in glaucoma. It has also developed a wide range of products for refractive correction, allowing people to improve their vision. Alcon AG works closely with leading ophthalmologists and opticians to optimize its product development. This close collaboration ensures that Alcon AG's products meet the needs of patients and provide them with high safety and effectiveness. With its innovative products and technologies, Alcon AG aims to improve the quality of life for patients and provide them with optimal care and treatment. Overall, Alcon AG is a leading company in ophthalmology, offering its customers a wide range of innovative and high-quality products. From diagnosis to care to surgical interventions, Alcon AG's product range covers all areas of ophthalmology. The company is known for its research and development and is constantly working towards advancing ophthalmology. Through its continuous innovation and customer orientation, Alcon AG has established a strong position in the healthcare industry and will continue to introduce new products and technologies in the future. Alcon is one of the most popular companies on Eulerpool.

Revenue Details

Understanding Alcon's Sales Figures

The sales figures of Alcon originate from the total revenue accrued from goods sold or services provided during a specific time period. These numbers are a direct reflection of the company’s ability to translate its products or services into revenue, indicating the demand and market presence.

Year-to-Year Comparison

Analyzing Alcon’s yearly sales data offers insights into the company’s growth and stability. An increase in sales suggests a growing demand for its offerings, efficient marketing, or expansion into new markets. Conversely, a decline might indicate market saturation, increased competition, or less effective strategies.

Impact on Investments

Investors often scrutinize Alcon's sales data to evaluate its financial health and growth prospects. Consistent sales growth can be a promising indicator of the company’s profitability and potential return on investment, influencing stock prices and investor confidence.

Interpreting Sales Fluctuations

Increases in Alcon’s sales indicate market growth, innovation, or effective marketing, often leading to a surge in stock prices. A decline, however, can signal challenges requiring strategic adjustments to enhance market share and profitability.

Frequently Asked Questions about Alcon stock

The revenue of Alcon is 10.40 B USD in 2026.

The revenue in assessing a stock

Revenue is an important financial measure used in the valuation of stocks. It is a measure of a company's economic activity and can serve as an indicator of the company's success. Revenue is considered one of the most important factors in stock valuation. In addition, revenue can also be used to calculate other financial measures such as earnings per share and price-earnings ratio.

History and utilization of revenue

Revenue has long been considered one of the most important financial indicators. It was used in the 19th century as one of the first financial indicators to measure a company's economic activity. Since then, revenue has been regularly used to evaluate companies.

Revenue is usually calculated as a percentage of the company's equity. It can also be used to determine the overall profitability of a company. There are many different types of revenue that can be used to measure a company's economic activity, such as gross revenue, net revenue, and revenue from international business.

The revenue can also be used to evaluate stocks. For example, the revenue of a company can be used to evaluate the success of the company. If a company has high revenue, it means that it is a profitable company because it has high demand for its products or services.

Calculation and Application of Revenue

In order to calculate a company's revenue, the company's income must be deducted from its expenses. The income can come from various sources, such as sales, licensing fees, services, etc. The expenses can include costs for production, procurement, inventory, sales, and administration.

The revenue can then be used to calculate various financial ratios. For example, the revenue can be used to calculate the price-earnings ratio (P/E ratio) of a company. This is a measure of a company's profitability, calculated by taking the ratio of the stock price to earnings per share.

Revenue can also be used to calculate earnings per share (EPS) of a company. This is a measure of a company's profit per share. EPS is calculated by dividing earnings by the number of shares issued.

Use of revenue by investors

Investors use revenue to evaluate stocks, as revenue is an indicator of a company's success. For example, an investor can compare a company's revenue to see how successful it is. An investor can also use a company's revenue to calculate its price-to-earnings ratio and earnings per share.

An example: An investor looks at a company that has a revenue of 25 million euros. He compares this revenue to that of the competitor, which has a revenue of 35 million euros. The investor can then see that the company with 25 million euros in revenue is less successful than the company with 35 million euros in revenue.

Advantages and Disadvantages of Revenue.

Revenue is a very useful tool for valuing stocks as it measures a company's economic activity. Revenue can also be used to calculate other financial ratios such as the price-earnings ratio and earnings per share.

However, one disadvantage is that revenue alone is not a meaningful indicator of a company's success. It is important to consider revenue in comparison to other financial metrics such as earnings per share and price-to-earnings ratio to get a complete picture of the company.

Access this data via the Eulerpool API

Income Statement — Alcon

All Key Metrics — Alcon